Author details

Full Name

Elisabetta Marangoni

Affiliation

ORCID

Career Start Year

1997

Papers

146

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37801608	Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers.	Cancer Res	2024
37536978	PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer.		2023
36223547	Tinengotinib (TT-00420), a Novel Spectrum-Selective Small-Molecule Kinase Inhibitor, Is Highly Active Against Triple-Negative Breast Cancer.	Molecular Cancer Therapeutics	2023
37914699	Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer.		2023
37725704	The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance.		2023
37633969	Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitor.	Cell Death Differ	2023
37958047	Incidence and Determinants of Acute Kidney Injury after Prone Positioning in Severe COVID-19 Acute Respiratory Distress Syndrome.		2023
37341140	Liver X receptors induce antiproliferative effects in basal-like breast cancer.		2023
37029129	Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.	Nat Commun	2023
37336117	Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis.	Cancer Treat Rev	2023
37458145	Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERÎ± breast cancer.		2023
37452026	Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers.	Nat Commun	2023
36695032	Ants act as olfactory bio-detectors of tumours in patient-derived xenograft mice.		2023
36621064	Pediatric recurrent acute necrotizing encephalomyelitis, RANBP2 genotype and Sars-CoV-2 infection: Diagnosis, pathogenesis and targeted treatments from a case study.		2023
37437610	Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: A systematic review and meta-analysis.		2023
36852691	HORMAD1 overexpression predicts response to anthracycline-cyclophosphamide and survival in triple-negative breast cancers.		2023
35302229	Recurrent pneumothorax after cesarean delivery in the critically ill pregnant with severe COVID-19 ARDS: a case report.	European Review for Medical and Pharmacological Sciences	2022
35452191	Kindlin-1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types.	Clinical and Translational Medicine	2022
35434898	Implementing subtype-specific pre-clinical models of breast cancer to study pre-treatment aspirin effects.	Cancer Med	2022
36002870	Correction: Using arterial-venous oxygen difference to guide red blood cell transfusion strategy.	Crit Care	2022
35365185	Targeting SHP2 phosphatase in breast cancer overcomes RTK-mediated resistance to PI3K inhibitors.	Breast Cancer Research	2022
35787660	Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.	Commun Biol	2022
35410383	H3K27me3 conditions chemotolerance in triple-negative breast cancer.	Nature Genetics	2022
36505864	<i>In vivo</i> efficacy assessment of the CDK4/6 inhibitor palbociclib and the PLK1 inhibitor volasertib in human chordoma xenografts.	Front Oncol	2022
36498656	Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients.		2022
36476873	Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis.		2022
36619972	Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach.	iScience	2022
33385260	Focus on renal blood flow in mechanically ventilated patients with SARS-CoV-2: a prospective pilot study.	Journal of Clinical Monitoring and Computing	2022
34927257	mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease.	International Journal of Cancer	2022
34496925	HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast.	J Hematol Oncol	2021
34020697	Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant.	Breast Cancer Research	2021
33542435	The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers.	Sci Rep	2021
34065180	Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer.	Cancers	2021
33889306	High and synergistic activity between mTORC1 and PLK1 inhibition in adenocarcinoma NSCLC.	Oncotarget	2021
33574090	YAP and Î²-Catenin Cooperate to Drive Oncogenesis in Basal Breast Cancer.	Cancer Research	2021
33886505	The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer.	JCI Insight	2021
33608030	Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients.	Critical Care	2021
33603134	Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer.	Scientific Reports	2021
34250755	mTOR Repression in Response to Amino Acid Starvation Promotes ECM Degradation Through MT1-MMP Endocytosis Arrest.	Advanced Science	2021
33923992	Co-Infections in Critically Ill Patients with or without COVID-19: A Comparison of Clinical Microbial Culture Findings.	International Journal of Environmental Research and Public Health	2021
34349666	Calculation of Transpulmonary Pressure From Regional Ventilation Displayed by Electrical Impedance Tomography in Acute Respiratory Distress Syndrome.	Frontiers in Physiology	2021
33421710	In vitro bone metastasis dwelling in a 3D bioengineered niche.	Biomaterials	2021
34849474	An avian embryo patient-derived xenograft model for preclinical studies of human breast cancers.	iScience	2021
32792481	PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance.	Nat Commun	2020
32075943	BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.	Sci Transl Med	2020
32424275	Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance.	Nat Cell Biol	2020
32315385	ShallowHRD: detection of homologous recombination deficiency from shallow whole genome sequencing.		2020
32312299	Using arterial-venous oxygen difference to guide red blood cell transfusion strategy.	Crit Care	2020
32307447	Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities.	Oncogene	2020
32005287	Correction to: Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer.	Breast Cancer Research	2020